Concurrent substance use among cancer patients with and without a history of cannabis use since cancer diagnosis at an NCI-Designated Cancer Center in Florida
High symptom burden may be associated with concurrent substance use with cannabis among cancer patients.
Authors
- Brian D. Gonzalez (ORCID: https://orcid.org/0000-0001-5108-5735)
- Sahana Rajasekhara (ORCID: https://orcid.org/0000-0003-3877-6165)
- Kea L. Turner (ORCID: https://orcid.org/0000-0002-7885-0879)
- Jessica Y. Islam (ORCID: https://orcid.org/0000-0002-3690-3848)
- Omar Garcia Rodriguez
- Kathleen M. Egan (ORCID: https://orcid.org/0000-0001-8772-6979)
- Oliver T. Nguyen (ORCID: https://orcid.org/0000-0003-2852-7106)
- Young D. Chang (ORCID: https://orcid.org/0000-0002-6884-2605)
- Heather S.L. Jim (ORCID: https://orcid.org/0000-0001-7353-3711)
- Yessica C. Martinez
- Diane Irlanda Rodriguez
Institutions
- University of South Florida (US)
- Moffitt Cancer Center (US)
Publication Details
- Journal
- JNCI Monographs
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1093/jncimonographs/lgad036
- Citations
- 2
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.90
Funders
- U.S. Department of Health and Human Services
- Moffitt Cancer Center
- National Institutes of Health
- National Cancer Institute